课题基金 / 基金详情

Role of ACK1 (activated Cdc42-associated kinase 1) in adaptor SLP-76 signalling in T-cells

Role of ACK1 (activated Cdc42-associated kinase 1) in adaptor SLP-76 signalling in T-cells
ACK1(激活的 Cdc42 相关激酶 1)在 T 细胞适配器 SLP-76 信号传导中的作用
批准号:
RGPIN-2017-06461
负责人:
Rudd, Christopher
金额:
$2.48万
依托单位:
依托单位国家:
加拿大
项目类别:
Discovery Grants Program - Individual
财政年份:
2017
资助国家:
加拿大
项目状态:
已结题
起止时间:
2017-01-01 至 2018-12-31

项目摘要

项目成果

Rudd, Christopher的其他基金

相似基金

相关文献

中文摘要
翻译
我们NSERC研究计划的目标是了解控制下游功能的抗原-受体近端信号事件,如钙动员和接头和激酶的聚集。介导T细胞激活的最初事件是由近端的酪氨酸激酶如p56lck和ZAP-70以及它们对接头蛋白的磷酸化所介导的。转接子反过来调节细胞内整合信号所需的复合体的形成。SLP-76(含76 kDa SH2结构域的白细胞蛋白)是一种关键的适配蛋白,它在促进T细胞的活化和发育中起着积极的作用。SLP-76含有一个无菌α基序(SAM)结构域,我们先前发现该结构域介导SLP-76二聚体和寡聚体的形成。我们还表明,酪氨酸激酶AcK1CDC42(细胞分裂周期42)激活的酪氨酸激酶1(AcK1或TNK2)与SLP-76结合,SLP-76 SAM结构域的丢失破坏了结合。TcR诱导磷脂酶C(PLCZAP-1)活化和钙动员的经典模型涉及另一种激酶γ-70及其磷酸化及其对白细胞介素2诱导的T细胞激酶的募集到SLP-76。我们发现,AcK1的表达诱导了SLP-76的磷酸化和钙内流,因此,SLP-76-AcK1模块可能是激活T细胞内钙动员和F-肌动蛋白组装的第二个模块途径。为了验证这一模型,我们提出:目标1:检测AcK1与SLP-76结合是否需要SAM结构域介导的寡聚。我们发现AcK1可以磷酸化这些关键酪氨酸上的SLP-76,并通过其SAM结构域与SLP-76结合。本文介绍了调节T细胞中SLP-76功能的新机制。
英文摘要
The goal of our NSERC research program is to understand the antigen-receptor proximal signaling events that control downstream functions such as calcium mobilization and the aggregation of adaptors and kinases. The initial events that mediate activation of T-cells are mediated by proximal tyrosine kinases such as p56lck and ZAP-70 and their phosphorylation of adaptor proteins. Adaptors in turn mediate the formation of complexes needed to integrate signalling in cells. One key adaptor protein is SLP-76 (SH2 domain containing leukocyte protein of 76kDa) which plays a positive role in promoting T cell activation and development. SLP-76 contains a sterile­ alpha motif (SAM) domain that we previously showed mediates SLP-76 dimer and oligomer formation. We have also shown that the tyrosine kinase ACK1 Cdc42 (cell division cycle 42)-activated tyrosine kinase 1 (ACK1 or Tnk2) binds to SLP-76 and that the loss of the SLP-76 SAM domain disrupts binding. The classic model for TCR induction of phospholipase C (PLCγ1) activation and calcium mobilization involves another kinase ZAP-70 and its phosphorylation and its recruitment of interleukin-2-inducible T-cell kinase (ITK) to SLP-76. We found that ACK1 expression induced SLP-76 phosphorylation and calcium influx, and as such, the SLP-76-ACK1 module could represent a second modular pathway for the activation calcium mobilization and F-actin assembly in T-cells. To test this model, we propose: Aim 1: to examine whether the SAM domain mediated oligomerization is needed for the binding of ACK1 to SLP-76. We have discovered that ACK1 can phosphorylate SLP-76 on these key tyrosines and binds to SLP-76 via its SAM domain. This introduces are novel mechanism to regulate SLP-76 function in T-cells.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Role of ACK1 (activated Cdc42-associated kinase 1) in adaptor SLP-76 signalling in T-cells
  • 批准号:
    RGPIN-2017-06461
  • 项目类别:
    Discovery Grants Program - Individual
  • 资助金额:
    $4.95万
  • 财政年份:
    2021
  • 负责人:
    Rudd, Christopher
  • 依托单位:
Role of ACK1 (activated Cdc42-associated kinase 1) in adaptor SLP-76 signalling in T-cells
  • 批准号:
    RGPIN-2017-06461
  • 项目类别:
    Discovery Grants Program - Individual
  • 资助金额:
    $2.48万
  • 财政年份:
    2020
  • 负责人:
    Rudd, Christopher
  • 依托单位:
Role of ACK1 (activated Cdc42-associated kinase 1) in adaptor SLP-76 signalling in T-cells
  • 批准号:
    RGPIN-2017-06461
  • 项目类别:
    Discovery Grants Program - Individual
  • 资助金额:
    $2.48万
  • 财政年份:
    2019
  • 负责人:
    Rudd, Christopher
  • 依托单位:
Role of ACK1 (activated Cdc42-associated kinase 1) in adaptor SLP-76 signalling in T-cells
  • 批准号:
    RGPIN-2017-06461
  • 项目类别:
    Discovery Grants Program - Individual
  • 资助金额:
    $2.48万
  • 财政年份:
    2018
  • 负责人:
    Rudd, Christopher
  • 依托单位:
国内基金
海外基金
选择性ACK1抑制剂的设计、合成及抗肿瘤活性研究
  • 批准号:
    --
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    30万元
  • 批准年份:
    2022
  • 负责人:
    郭靖
  • 依托单位:
ACK1/TNK2在嗜神经肠道病毒感染扩散中的作用机制研究
  • 批准号:
    --
  • 项目类别:
    面上项目
  • 资助金额:
    54万元
  • 批准年份:
    2022
  • 负责人:
    蒋红兵
  • 依托单位:
Lnc-MPLKIP-6竞争性抑制SIAH1介导的ACK1泛素化调控肺腺癌EGFR-TKI耐药的机制研究
  • 批准号:
    --
  • 项目类别:
    面上项目
  • 资助金额:
    55万元
  • 批准年份:
    2021
  • 负责人:
    马建群
  • 依托单位:
Ack1介导新型EGFR三代抑制剂120067耐药机制研究
  • 批准号:
    81903638
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    20.0万元
  • 批准年份:
    2019
  • 负责人:
    张弢
  • 依托单位: